首页> 外文OA文献 >Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein.
【2h】

Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein.

机译:腺瘤性息肉病(APC)肿瘤抑制蛋白对细胞内β-catenin水平的调节。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The APC tumor-suppressor protein associates with beta-catenin, a cell adhesion protein that is upregulated by the WNT1 oncogene. We examined the effects of exogenous APC expression on the distribution and amount of beta-catenin in a colorectal cancer cell containing only mutant APC. Expression of wild-type APC caused a pronounced reduction in total beta-catenin levels by eliminating an excessive supply of cytoplasmic beta-catenin indigenous to the SW480 colorectal cancer cell line. This reduction was due to an enhanced rate of beta-catenin protein degradation. Truncated mutant APC proteins, characteristic of those associated with cancer, lacked this activity. Mutational analysis revealed that the central region of the APC protein, which is typically deleted or severely truncated in tumors, was responsible for the down-regulation of beta-catenin. These results suggest that the tumor-suppressor activity of mutant APC may be compromised due to a defect in its ability to regulate beta-catenin.
机译:APC肿瘤抑制蛋白与β-catenin结合,后者是一种由WNT1癌基因上调的细胞粘附蛋白。我们检查了外源APC表达对仅包含突变APC的结直肠癌细胞中β-catenin分布和数量的影响。野生型APC的表达通过消除SW480大肠癌细胞系固有的过量胞质β-catenin的供应而导致总β-catenin水平的明显降低。这种减少是由于β-catenin蛋白降解率提高。具有癌症相关特征的截短突变APC蛋白缺乏这种活性。突变分析显示,APC蛋白的中央区域通常在肿瘤中被删除或严重截断,这是β-catenin下调的原因。这些结果表明,突变型APC的肿瘤抑制活性可能由于其调节β-catenin的能力缺陷而受到损害。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号